Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Roswell Park Cancer Institute
Stanford University
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
University of California, San Francisco
University of Southern California
University of Iowa
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Yale University
Emory University
Columbia University
National Cancer Institute (NCI)
INSYS Therapeutics Inc